-
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Given Average Rating of "Moderate Buy" by Brokerages
Source: Buzz FX / 07 Oct 2024 02:11:11 America/Chicago
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Given Average Rating of "Moderate Buy" by Brokerages Written by MarketBeat October 7, 2024 Share Link copied to clipboard. Shares of Neurocrine Biosciences, Inc.
Read more...